Navigating the AI Landscape in Healthcare: Ethics and Access

By Sumona Bose

December 11, 2023

The AI Challenge in Healthcare

The integration of Artificial Intelligence (AI) into the healthcare sector is a complex endeavour. Life sciences consulting firms are grappling with significant challenges, particularly when it comes to embedding AI-enabled diagnostics into healthcare systems. These challenges are rooted in sociocultural, technological, and institutional subsystems. The medical community’s prevailing ethos, concerns about black-box decision-making, and fear of reputational harm are some of the factors contributing to resistance against AI.

The Response: Stealth Science, Agility, and Digital Ambidexterity

AI providers are responding to these challenges with three key practices: stealth science, agility, and digital ambidexterity. Stealth science involves maintaining opacity around development to safeguard trade secrets and evade regulatory scrutiny. Agility refers to the capacity to adapt to different technical settings and learn from various healthcare environments. Lastly, digital ambidexterity is the pursuit of efficiency and innovation in developing AI technologies.

However, these practices may lead to complexities in technology spread, regulatory challenges, and shifts in healthcare dynamics. It’s clear that the journey towards integrating AI into healthcare is filled with paradoxes, with AI providers having to tread a fine line between acceleration and inertia.

The Ethical Considerations

From policy makers, ethics in access to AI is an important factor to consider. AI providers need to ensure that their practices allow for more latitude in navigating healthcare systems, but this must be balanced against the need for transparency and accountability.

To ensure value-based healthcare, we must address these ethical dilemmas head-on and work towards finding workable solutions. AI consulting firms must work in tandem with healthcare providers and policy-makers to create human-centred solutions that respect the rights and needs of all stakeholders.

Reference url

Recent Posts

Inequality-Adjusted ICER: Enhancing Cost-Effectiveness in Health Technology Evaluation

By HEOR Staff Writer

April 13, 2026

The inequality-adjusted ICER offers a practical way to embed explicit trade-offs between maximising total population health and reducing health inequality directly into cost-effectiveness analysis. By dividing the conventional ICER by an inequality-adjusted ICER, analysts derive a health inequali...
Semaglutide Distribution Flexibility: EMA Approves Room Temperature Delivery for Wegovy®
The European Medicines Agency (EMA) has granted an important update to the product information for Wegovy (semaglutide), introducing semaglutide distribution flexibility that allows controlled-temperature delivery at up to 30°C for up to 48 hours during the final leg from pharmacies to patients. ...
Shift in Portuguese Pediatric Vaccination Policy: Evolving Perspectives on Risk and Benefit

By João L. Carapinha

April 10, 2026

Portuguese Pediatric Vaccination is now restricted to children with specific high-risk conditions, following the exact approach recommended by pharmaceutical experts in 2021. Portuguese health authorities have abandoned universal COVID-19 vaccination for children, limiting the program to those ag...